Delivery Order SPE2DB22D3010-SPE2DB25FP1VM

Award Date 3/6/25
Potential Completion Date 3/7/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,425.94, is a firm fixed-price delivery order for the supply of IBSRELA 50 MG TABLET UU 60S, a medical product. The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,763.74 firm fixed-price delivery order is for the medical product "IBSRELA 50 MG TABLET UU 60S" with a completion date of February 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,790.45 firm-fixed-price delivery order is for the supply of IBSRELA 50 MG TABLET, a prescription drug product, to support government healthcare programs. The award does not have a set-aside designation. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December...
This federal contract award is a Delivery Order valued at $10,091.76 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is with the Defense Logistics Agency (DLA), an agency within the Department of Defense, to provide the pharmaceutical product IBSRELA 50 MG TABLET UU 60S. The contract has an ultimate completion date of November 7, 2024 and utilizes a Firm Fixed Price pricing type. This award is not associated with a set-aside...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $13,242.25 Delivery Order contract is for the provision of IBSRELA 50 MG TABLET in 60-count units. The contract is a Firm Fixed Price arrangement with a completion date of June 27, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,814.04 Firm Fixed Price delivery order is for the supply of IBSRELA 50 MG TABLET medication to support military healthcare programs. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,008.50 firm fixed-price delivery order contract has an ultimate completion date of December 30, 2024 and is not designated as a set-aside. The contract provides for the delivery of IBSRELA 50 MG TABLET, a pharmaceutical product, to support military treatment facilities, veterans' healthcare programs, and other...
This federal contract award, valued at $41,958.32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of IBSRELA 50 MG TABLET, a pharmaceutical product, and has an ultimate completion date of July 8, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to Amerisourcebergen Drug Corp's Corporate Office division. The $21,910.84 firm fixed-price delivery order is for the supply of IBSRELA 50 MG TABLET, a pharmaceutical product, to support the healthcare needs of government agencies and military treatment facilities. The contract has an ultimate completion date of October 10, 2024. Amerisourcebergen, a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of IBSRELA 50 MG TABLET UU 60S. The contract, with a ceiling value of $6,486.85, is a delivery order type with firm fixed pricing. The period of performance is from the award date of October 11, 2024 through October 15, 2024. This contract award is not designated as a set-aside. AmerisourceBergen has a significant Indefinite...
  • SPE2DB22D3010
    Indefinite Delivery Contract
  • SPE2DB22D3010-SPE2DB25FP1VM
    Delivery Order

This federal contract award, valued at $2,149.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the medical product "IBSRELA 50 MG TABLET UU 60S", with a completion date of March 7, 2025.

The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 6/5/25, 10:18 AM